跳至主要内容
临床试验/ACTRN12611001094965
ACTRN12611001094965招募中未知

The Effect of Whole-Body Vibration Treatment on Bone Metabolism in Breast Cancer Survivors who are undergoing Aromatase Inhibitor Therapy

Dr Michael Baker0 个研究点目标入组 50 人开始时间: 2011年10月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Female

入选标准

  • Currently taking an Aromatase Inhibitor drug for the treatment of breast cancer;
  • Willing to continue taking any bone altering medications or supplements they were previously taking for the duration of the study, including calcium and vitamin D;
  • Able to stand unassisted for sustained periods of time (i.e. 20 minutes)

排除标准

  • Currently taking bisphosphonate medication;
  • Cognitive impairment;
  • Contraindications to vibration platform training (including pacemaker and fracture within the past six months);
  • Diagnosis of bone metastasis, and
  • Diagnosis of diseases other than osteoporosis affecting bone

研究者

发起方
Dr Michael Baker

相似试验